Financing, Equity Capital Markets
Madrigal Pharmaceuticals, Inc.
03/24
|
$600.0 Million
![Madrigal Pharmaceuticals, Inc.](/sites/default/files/images/custom/madrigal_pharmaceuticals_inc._slide_1_image.jpg)
Piper Sandler served as bookrunner for Madrigal Pharmaceuticals, Inc. on a confidentially marketed follow-on offering